EP0804204A4 - Treatment of medical disorders associated with free radical formation - Google Patents

Treatment of medical disorders associated with free radical formation

Info

Publication number
EP0804204A4
EP0804204A4 EP94930119A EP94930119A EP0804204A4 EP 0804204 A4 EP0804204 A4 EP 0804204A4 EP 94930119 A EP94930119 A EP 94930119A EP 94930119 A EP94930119 A EP 94930119A EP 0804204 A4 EP0804204 A4 EP 0804204A4
Authority
EP
European Patent Office
Prior art keywords
treatment
free radical
disorders associated
radical formation
medical disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94930119A
Other languages
German (de)
French (fr)
Other versions
EP0804204A1 (en
Inventor
Theodore Macrides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JW Broadbent Nominees Pty Ltd
Original Assignee
JW Broadbent Nominees Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JW Broadbent Nominees Pty Ltd filed Critical JW Broadbent Nominees Pty Ltd
Publication of EP0804204A1 publication Critical patent/EP0804204A1/en
Publication of EP0804204A4 publication Critical patent/EP0804204A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP94930119A 1993-10-12 1994-10-12 Treatment of medical disorders associated with free radical formation Withdrawn EP0804204A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM175293 1993-10-12
AUPM1752/93 1993-10-12
PCT/AU1994/000619 WO1995010283A1 (en) 1993-10-12 1994-10-12 Treatment of medical disorders associated with free radical formation

Publications (2)

Publication Number Publication Date
EP0804204A1 EP0804204A1 (en) 1997-11-05
EP0804204A4 true EP0804204A4 (en) 1998-04-22

Family

ID=3777265

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94930119A Withdrawn EP0804204A4 (en) 1993-10-12 1994-10-12 Treatment of medical disorders associated with free radical formation

Country Status (4)

Country Link
EP (1) EP0804204A4 (en)
CA (1) CA2170591A1 (en)
WO (1) WO1995010283A1 (en)
ZA (1) ZA947912B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2760362B1 (en) * 1997-03-10 2000-08-11 Vitasterol COSMETIC OR DERMATOLOGICAL USE OF 7-HYDROXYL STEROIDS
JP2007500227A (en) * 2003-05-29 2007-01-11 ミトス・ファーマシューティカルズ・インコーポレーテッド Use of nitroxides in connection with photosensitizers and sound sensitizers
CA2656320C (en) 2006-06-27 2015-04-28 Intercept Pharmaceuticals, Inc. Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
GB0625966D0 (en) * 2006-12-23 2007-02-07 Renovo Ltd Medicaments and methods for promoting wound contraction
PL2793897T3 (en) * 2011-12-20 2017-10-31 Mcfarlane Marketing Aust Pty Ltd Treatment of seborrhoea

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007903A1 (en) * 1991-10-16 1993-04-29 Richardson-Vicks, Inc. Enhanced skin penetration system for improved topical delivery of drugs
WO1993007856A1 (en) * 1991-10-16 1993-04-29 Richardson-Vicks, Inc. LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES
WO1993007902A1 (en) * 1991-10-16 1993-04-29 Richardson-Vicks, Inc. Enhanced skin penetration system for improved topical delivery of drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA876171B (en) * 1986-08-21 1988-10-26 Broadbent James Meredyth Active principle isolated from shark tissue
WO1989007607A1 (en) * 1988-02-19 1989-08-24 Broadbent, James, Meredyth 24r-scymnol, and preparation and use thereof
KR920702687A (en) * 1990-06-30 1992-10-06 쓰무라 아키라 Bile alcohols and pharmaceutical compositions containing them as active ingredients

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007903A1 (en) * 1991-10-16 1993-04-29 Richardson-Vicks, Inc. Enhanced skin penetration system for improved topical delivery of drugs
WO1993007856A1 (en) * 1991-10-16 1993-04-29 Richardson-Vicks, Inc. LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES
WO1993007902A1 (en) * 1991-10-16 1993-04-29 Richardson-Vicks, Inc. Enhanced skin penetration system for improved topical delivery of drugs

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9510283A1 *
SYROV ET AL.: "Steroid genins and glycosides as antiinflammatory agents", KHIM. FARM. ZH., vol. 26, no. 5, 1992, pages 71 - 76, XP002054560 *

Also Published As

Publication number Publication date
ZA947912B (en) 1995-05-24
CA2170591A1 (en) 1995-04-20
EP0804204A1 (en) 1997-11-05
WO1995010283A1 (en) 1995-04-20

Similar Documents

Publication Publication Date Title
AU7545594A (en) Implantable device for the treatment of aedemas
EP0460912A3 (en) Medicaments for the treatment of sexual disorder
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
AU1173195A (en) Treatment of immunoregulatory disorders
ZA958725B (en) Treatment of disorders with duloxetine
AU2807492A (en) Use of misoprostol for the treatment of allergy
GB9201920D0 (en) Novel treatment i
ZA947912B (en) Treatment of medical disorders associated with free radical formation
IL104755A0 (en) Treatment of glaucoma
GB9419048D0 (en) Treatment of muscular disorders
GB9217124D0 (en) Medical treatment
GB8715914D0 (en) Treatment of cerabral disorders
GB9216360D0 (en) Treatment of blood
GB9223953D0 (en) Treatment of eye disorders
GB2266241B (en) Treatment of pastures
AU5397994A (en) Treatment of skin disorders
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
IE900102L (en) Treatment of skin disorders
GB9125670D0 (en) Treatment of neurogical conditions
GB9226313D0 (en) Therapeutic treatment
BG98001U (en) Medicament for the treatment of hyperkeratotic conditions of the skin
IE901990L (en) Treatment of gut disorders
GB9207595D0 (en) Treatment of pastures
IL106917A0 (en) Compositions for the treatment of skin disorders
GB9303688D0 (en) Therapeutic treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960417

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19980309

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

17Q First examination report despatched

Effective date: 19990527

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19991007